In vitro interactions of the new anorexic agent WY-5244 with cardiac and vascular tissue and with adrenergic mechanisms.
D000818:Animals; D001011:Aorta; D001067:Appetite Depressants / Q000494:pharmacology*; D002319:Cardiovascular System / Q000187:drug effects*; D002415:Cats; D003913:Dextroamphetamine / Q000494:pharmacology; D004336:Drug Antagonism; D004558:Electric Stimulation; D006145:Guanethidine / Q000494:pharmacology; D006168:Guinea Pigs; D006325:Heart Atria; D006339:Heart Rate / Q000187:drug effects; D007099:Imipramine / Q000494:pharmacology; D066298:In Vitro Techniques; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects*; D009638:Norepinephrine / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D011817:Rabbits; D013566:Sympathomimetics / Q000494:pharmacology*; D014649:Vas Deferens
D001067:Appetite Depressants; D013566:Sympathomimetics; D010643:Phenoxybenzamine; D007099:Imipramine; D003913:Dextroamphetamine; D009638:Norepinephrine; D006145:Guanethidine